Novavax Inc NVAX:NASDAQ

Last Price$41.47NASDAQ Previous Close - Last Trade as of 4:00PM ET 8/12/22

Today's Change0(0.00%)
Bid (Size)$41.51 (20)
Ask (Size)$41.63 (5)
Day Low / HighN/A - N/A
Volume5.0 M
 

View Biotechnology IndustryPeer Comparison as of 08/12/2022

 

Novavax Inc ( NASDAQ )

Price: $41.47
Change: +1.13 (2.80%)
Volume: 5.0 M
4:00PM ET 8/12/2022
 
 

Fate Therapeutics Inc ( NASDAQ )

Price: $33.82
Change: +1.17 (3.58%)
Volume: 1.4 M
4:00PM ET 8/12/2022
 
 

Twist Bioscience Corp ( NASDAQ )

Price: $52.97
Change: +3.89 (7.93%)
Volume: 892.1 K
4:00PM ET 8/12/2022
 
 

Arvinas Inc ( NASDAQ )

Price: $54.46
Change: -0.08 (0.15%)
Volume: 397.5 K
4:00PM ET 8/12/2022
 
 

BioCryst Pharmaceuticals Inc ( NASDAQ )

Price: $14.64
Change: +0.27 (1.88%)
Volume: 2.8 M
4:00PM ET 8/12/2022
 

Read more news Recent News

Novavax COVID-19 Vaccine Receives Approval in South Korea for Use in Adolescents
9:51AM ET 8/12/2022 MT Newswires

Novavax (NVAX) said Friday that its partner SK bioscience obtained approval from South Korea's drug safety regulator for the use of its COVID-19 vaccine in...

Novavax Gets Thai Regulator's Emergency Use Authorization for COVID-19 Vaccine for Ages 12 Through 17
10:14AM ET 8/10/2022 MT Newswires

Novavax (NVAX) said Wednesday that Thailand's Food and Drug Administration has granted expanded emergency use authorization for its vaccine to prevent...

--B. Riley Securities Lowers Novavax's Price Target to $126 from $171 After Lower-than-Expected Q2 Results, Maintains Buy Rating
9:45AM ET 8/10/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Sector Update: Health Care Stocks Posting Modest Tuesday Advance
1:47PM ET 8/09/2022 MT Newswires

Health care stocks were moderately higher this afternoon, with the NYSE Health Care Index rising 0.3% while the SPDR Health Care Select Sector ETF (XLV)...

Company Profile

Business DescriptionNovavax, Inc. focuses on the discovery, development and commercialization of vaccines to prevent infectious diseases. It provides vaccines for COVID-19, seasonal flu, respiratory syncytial virus, Ebola, and Middle East respiratory syndrome. The company was founded in 1987 and is headquartered in Gaithersburg, MD. View company web site for more details
Address21 Firstfield Road
Gaithersburg, Maryland 20878
Phone+1.240.268.2000
Number of Employees379
Recent SEC Filing08/09/2022S-8
President, Chief Executive Officer & DirectorStanley C. Erck
Chief Operating Officer & Executive Vice PresidentRichard Crowley
Chief Financial Officer, Treasurer & Executive VPJames Patrick Kelly
Chief Scientist & Senior Vice President-DiscoveryGale E. Smith

Company Highlights

Price Open$41.16
Previous Close$40.34
52 Week Range$34.88 - 277.80
Market Capitalization$3.2 B
Shares Outstanding78.1 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement11/03/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$19.51
Beta vs. S&P 500N/A
Revenue$34.3 M
Net Profit Margin-114.32%
Return on Equity2,439.70%

Analyst Ratings as of 08/09/2022

Buy
4
Overweight
0
Hold
3
Underweight
1
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset